Videos On Demand
21/05/2021
11.30-13.00 The Most Impactful Antithrombotic Trials in 2020-2021. Highlights from ACC 21
RIVER - ATLANTIS - Michail Botis
273 Views
LAAO III - Gregory Pattakos
256 Views
Dubius, POPular AGE, POPular TAVI, ADAPTABLE, TALOS AMI, HOST-EXAM - John Goudevenos
265 Views
POPular CABG - Theodora Bampali
257 Views
VOYAGER - PAD - Petroula Nana
499 Views
DIRECT - MT - Dimitrios Nikas
294 Views
COMPARE CRASH - Dimitrios Alexopoulos
281 Views
FOXTROT - Alexandros Tselepis
268 Views
13.00-14.30 Clinical Seminar: Uncertainties and challenges in anticoagulation therapy
A patient with renal insufficiency - What is the optimal anticoagulation? - Dimitrios Vlahakos
248 Views
Subclinical atrial fibrillation is detected in a patient - When to anticoagulate? - Konstantinos Zekios
272 Views
Anticoagulant Reversal Agents: Who, What, When, and How? - Christos Katsouras
272 Views
Cardiac Surgery in the COVID-19 Era - Dimitrios Iliopoulos
254 Views
Choice of anticoagulant therapy in coexisting clinical diseases. Α clinical case of a 75 year old woman - Konstantinos Vemmos
271 Views
15.30-17.00 Indications, contraindications, and precautions with the use of DOACs
Use of DOACs in Patients with AF and Valvular Heart Lesions - Dimitrios Richter
260 Views
DOACs in adults with congenital heart disease - Eugenia Tsagalidou
265 Views
Anticoagulation and Stroke Prevention for AF: Stroke Prophylaxis in Complicated Cases - Odysseas Kargiotis
281 Views
End-Stage Renal Disease and Haemodialysis. Antiplatelets - Anticoagulants - Konstantinos Siontis (USA)
244 Views
17.30-19.00 Meet the Experts. Stroke management: specific issues
Intravenous Thrombolysis for acute ischemic stroke: ESO recommendations - Georgios Tsivgoulis
260 Views
How to Manage a Patient after Thrombolysis and Mechanical Thrombectomy - Panagiotis Mitsias
272 Views
The uncertainty of timing of anticoagulation initiation after cardioembolic Stroke - Sotirios Giannopoulos
253 Views
Restarting stroke prevention treatment in intracranial hemorrhage survivors - John Ellul
262 Views
19.00-20.00 Plenary Session. COVID-19 coagulopathy: What we know and how to treat
The unique characteristics of COVID-19 coagulopathy - Efrosyni Nomikou
275 Views
Coagulation Tests in COVID-19 patients: When to perform -risk stratification - Vasiliki Danilatou
286 Views
Management of coagulopathy in COVID-19 patients. Recent advances - Elias Kiriakou
283 Views
20.00-20.20 Keynote Lecture
Virtual management of thrombosis and anticoagulation: the way of the future? - James Douketis (Canada)
280 Views
20.20-20.45 Official Opening of ALPIC 2020
Welcome Addresses
332 Views
20.45-21.10 Opening Lecture
The Psychological and Social Impact of the Quarantine in COVID-19 Pandemic - Thanos Askitis
241 Views
22/05/2021
08.30-10.00 How to Treat Session. Practical Guidance in Antithrombotic Therapy
Managing Tough Anticoagulation Cases - What Would YOU Do? - Kalliroi Kalantzi
239 Views
A 60 Years Old Patient with Pancreatic Cancer Who Develops A Pulmonary Embolism - Konstantinos Pappas
265 Views
A 70 Years Old Patient with ESRD and Atrial Fibrillation - Athanasios Pipilis
239 Views
Α pregnant woman with mechanical valve thrombosis - Gregory Pattakos
246 Views
The do’s and the don’ts in a hypertensive patient with Transient ischemic attack - Christos Savopoulos
283 Views
10.30-11.30 Advanced Clinical Workshop: Antithrombotics in Coronary Artery Disease
Antithrombotic Treatment before, during and after PCI - Dimitrios Alexopoulos
272 Views
Bleeding after an ACS: what are you doing with the antithrombotic therapy - Eugenia Pappa
237 Views
Antithrombotic therapy for patients with chronic coronary syndromes - John Kanakakis
315 Views
11.30-12.00 Satellite Lecture
Up to date on anticoagulant therapy in patients with Acute Coronary Syndrome/ PCI in atrial fibrillation. - Leonidas Poulimenos
390 Views
12.00-13.30 Meet the Experts session: Risk assessment of thrombosis in hematological disorders
Thromboinflammation and sickle cell disease - Efthimia Vlachaki
249 Views
Multiple myeloma - associated coagulopathy - Evdoxia Hatjiharissi
247 Views
Thrombotic complications of myeloproliferative neoplasms - Elissavet Grouzi
273 Views
PNH associated thrombosis - Styliani Kokkori
254 Views
Mechanisms and management of coagulopathy in acute promyelocytic leukemia - Vassilios Perifanis
280 Views
13.30-14.30 Clinical Seminar. Management of acute ischemic stroke
Dissolving the thrombus - Vasilios Papavasileiou
328 Views
Dissolving the thrombus in a patient on anticoagulation - Georgios Ntaios
265 Views
Retrieving the embolus - Panagiotis Papanagiotou
368 Views
15.30-17.00 Plenary session: New Insights in Cancer-Associated Thrombosis (CAT)
Pathophysiological mechanisms underlying CAT - Alexandros Tselepis
297 Views
Biomarkers for CAT prediction - Benjamin Brenner (Israel)
281 Views
Treatment of bleeding in cancer patients - Stavroula Tsiara
392 Views
Anticoagulants in CAT. When to choose a LMWH or a DOAC? - Miltiadis Matsagkas
249 Views
Prevention and treatment of CAT practice guidelines. Consensus or Confusion? - James Douketis (Canada)
250 Views
17.30-19.30 Meet the Experts. Perioperative Management of Antithrombotics
Perioperative management of antiplatelets. An update - Petros Tzimas
250 Views
Thromboprophylaxis in Orthopaedic interventions - Anastasios Korompilias
257 Views
VTE prevention for patients undergoing major Surgery for gastrointestinal and hepato-pancreato-biliary malignancies - Georgios Glantzounis
208 Views
Perioperative myocardial infarction in the twilight zone between a surgeon and a cardiologist. The role of anaesthesiologist - Eleni Arnaoutoglou
248 Views
DOACs Timing of interruption before elective procedures or surgery - Dimitrios Nikas
218 Views
DAPI in PAD. Just indications or evidence? - Miltiadis Matsagkas
214 Views
Perioperative anticoagulant management: what have we learned in 2020? - James Douketis (Canada)
204 Views
19.30-19.50 Keynote Lecture
Anticoagulant Strategies for Thromboprophylaxis in Sick, Hospitalized COVID-19 Patients - Alex Spyropoulos (USA)
198 Views
19.50-21.20 Plenary Session. New insights into the role of PCSK9 and Lipoproteins in Atherosclerosis and Thrombosis. From Pathophysiology to Therapy
PCSK9 in Atherosclerosis and Thrombosis - Lipids and Beyond - Alexandros Tselepis
204 Views
Eligibility for PCSK9 Inhibitors Treatment in ACS and chronic coronary artery disease - Evangelos Liberopoulos
203 Views
Stroke Prevention with PCSK9 Inhibitors - Haralampos Milionis
216 Views
Efficacy and Safety of PCSK9 Inhibitors in Patients with Low Extremity Arterial Disease - Vasileios Kotsis
187 Views
The Effect of PCSK9 Inhibition on the VTE Risk - Theodosios Filippatos
226 Views
23/05/2021
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
Secondary prevention in patients with cryptogenic stroke and PFO - Nikolaos Kakaletsis
234 Views
Atrial cardiomyopathy and ischemic stroke: definition, relationships and antithrombotic treatment - Panagiotis Korantzopoulos
224 Views
Lipid lowering treatment in the secondary prevention of ischemic stroke - Fotios Barkas
200 Views
Non-stenotic atheromatous plaques and cryptogenic embolic stroke: potential relationship, attributable risk and management - Matilda Florentin
196 Views
Anemia and stroke: Where do we stand? - Georgia Kaiafa
199 Views
COVID-19 and ischemic stroke - Dimitrios Sagris
226 Views
11.30-12.30 Challenging the risk and management in Women Thrombosis
Hormones, venous and arterial thrombosis in Women - Ploutarchos Tzoulis
211 Views
To screen or not to screen for thrombophilia in a Pregnant Women or in a Women trying to conceive? - Eleftheria Lefkou
196 Views
Thrombosis in pregnancy: Prophylaxis and treatment - Sue Pavord (UK)
214 Views
12.30-14.30 Plenary Session. Recent Advances in VTE pathophysiology and treatment
New insights into the pathophysiology of VTE - Teresa Padró (Spain)
204 Views
Contribution of thrombophilia to the development of chronic thromboembolic pulmonary hypertension (CTEPH) - Vittorio Pengo (Italy)
185 Views
How to treat pediatric venous thromboembolic disease - Gili Kenet (Israel)
211 Views
Managing pulmonary embolism posthospital discharge - Joao Morais (Portugal)
245 Views
Conclusions
228 Views
21/05/2021
11.30-13.00 The Most Impactful Antithrombotic Trials in 2020-2021. Highlights from ACC 21
13.00-14.30 Clinical Seminar: Uncertainties and challenges in anticoagulation therapy
15.30-17.00 Indications, contraindications, and precautions with the use of DOACs
17.30-19.00 Meet the Experts. Stroke management: specific issues
19.00-20.00 Plenary Session. COVID-19 coagulopathy: What we know and how to treat
20.00-20.20 Keynote Lecture
20.20-20.45 Official Opening of ALPIC 2020
20.45-21.10 Opening Lecture
22/05/2021
08.30-10.00 How to Treat Session. Practical Guidance in Antithrombotic Therapy
10.30-11.30 Advanced Clinical Workshop: Antithrombotics in Coronary Artery Disease
11.30-12.00 Satellite Lecture
12.00-13.30 Meet the Experts session: Risk assessment of thrombosis in hematological disorders
13.30-14.30 Clinical Seminar. Management of acute ischemic stroke
15.30-17.00 Plenary session: New Insights in Cancer-Associated Thrombosis (CAT)
17.30-19.30 Meet the Experts. Perioperative Management of Antithrombotics
19.30-19.50 Keynote Lecture
19.50-21.20 Plenary Session. New insights into the role of PCSK9 and Lipoproteins in Atherosclerosis and Thrombosis. From Pathophysiology to Therapy
23/05/2021
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
11.30-12.30 Challenging the risk and management in Women Thrombosis
12.30-14.30 Plenary Session. Recent Advances in VTE pathophysiology and treatment
'Εξοδος